9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Pharmacological Treatment in Forensic Psychiatry—A Systematic Review

      systematic-review

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background: Pharmacological treatment is of great importance in forensic psychiatry, and the vast majority of patients are treated with antipsychotic agents. There are several systematic differences between general and forensic psychiatric patients, e.g. severe violent behavior, the amount of comorbidity, such as personality disorders and/or substance abuse. Based on that, it is reasonable to suspect that effects of pharmacological treatments also may differ. The objective of this systematic review was to investigate the effects of pharmacological interventions for patients within forensic psychiatry.

          Methods: The systematic review protocol was pre-registered in PROSPERO (CRD42017075308). Six databases were used for literature search on January 11, 2018. Controlled trials from forensic psychiatric care reporting on the effects of antipsychotic agents, mood stabilizers, benzodiazepines, antidepressants, as well as pharmacological agents used for the treatment of addiction or ADHD, were included. Two authors independently reviewed the studies, evaluated risk of bias and assessed certainty of evidence using Grading of Recommendations Assessment, Development and Evaluation (GRADE).

          Results: The literature search resulted in 1783 records (titles and abstracts) out of which 10 studies were included. Most of the studies included were retrospective and non-randomized. Five of them focused on treatment with clozapine and the remaining five on other antipsychotics or mood stabilizers. Five studies with a high risk of bias indicated positive effects of clozapine on time from treatment start to discharge, crime-free time, time from discharge to readmission, improved clinical functioning, and reduction in aggressive behavior. Psychotic symptoms after treatment were more pronounced in the clozapine group. Mainly due to the high risk of bias the reliability of the evidence for all outcomes was assessed as very low.

          Conclusion: This systematic review highlights the shortage of knowledge on the effectiveness of pharmacological treatment within forensic psychiatry. Due to very few studies being available in this setting, as well as limitations in their execution and reporting, it is challenging to overview the outcomes of pharmacological interventions in this context. The frequent use of antipsychotics, sometimes in combination with other pharmacological agents, in this complex and heterogeneous patient group, calls for high-quality studies performed in this specific setting.

          Related collections

          Most cited references24

          • Record: found
          • Abstract: found
          • Article: not found

          Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study.

          To study the association between prescribed antipsychotic drugs and outcome in schizophrenia or schizoaffective disorder in the community. Prospective cohort study using national central registers. Community care in Finland. Nationwide cohort of 2230 consecutive adults hospitalised in Finland for the first time because of schizophrenia or schizoaffective disorder, January 1995 to December 2001. Rates of discontinuation of drugs (all causes), rates of rehospitalisation, and mortality associated with monotherapy with the 10 most commonly used antipsychotic drugs. Multivariate models and propensity score methods were used to adjust estimates of effectiveness. Initial use of clozapine (adjusted relative risk 0.17, 95% confidence interval 0.10 to 0.29), perphenazine depot (0.24, 0.13 to 0.47), and olanzapine (0.35, 0.18 to 0.71) were associated with the lowest rates of discontinuation for any reason when compared with oral haloperidol. During an average follow-up of 3.6 years, 4640 cases of rehospitalisation were recorded. Current use of perphenazine depot (0.32, 0.22 to 0.49), olanzapine (0.54, 0.41 to 0.71), and clozapine (0.64, 0.48 to 0.85) were associated with the lowest risk of rehospitalisation. Use of haloperidol was associated with a poor outcome among women. Mortality was markedly raised in patients not taking antipsychotics (12.3, 6.0 to 24.1) and the risk of suicide was high (37.4, 5.1 to 276). The effectiveness of first and second generation antipsychotics varies greatly in the community. Patients treated with perphenazine depot, clozapine, or olanzapine have a substantially lower risk of rehospitalisation or discontinuation (for any reason) of their initial treatment than do patients treated with haloperidol. Excess mortality is seen mostly in patients not using antipsychotic drugs.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            European Psychiatric Association (EPA) guidance on forensic psychiatry: Evidence based assessment and treatment of mentally disordered offenders

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Inpatient forensic-psychiatric care: Legal frameworks and service provision in three European countries.

              Laws governing the detention and treatment of mentally disordered offenders (MDOs) vary widely across Europe, yet little information is available about the features of these laws and their comparative advantages and disadvantages. The purpose of this article is to compare the legal framework governing detention in forensic psychiatric care in three European countries with long-established services for MDOs, England, Germany and the Netherlands. A literature review was conducted alongside consultation with experts from each country. We found that the three countries differ in several areas, including criteria for admission, review of detention, discharge process, the concept of criminal responsibility, service provision and treatment philosophy. Our findings suggest a profound difference in how each country relates to MDOs, with each approach contributing to different pathways and potentially different outcomes for the individual. Hopefully making these comparisons will stimulate debate and knowledge exchange on an international level to aid future research and the development of best practice in managing this population.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Psychiatry
                Front Psychiatry
                Front. Psychiatry
                Frontiers in Psychiatry
                Frontiers Media S.A.
                1664-0640
                16 January 2020
                2019
                : 10
                : 963
                Affiliations
                [1] 1 Department of Clinical Neuroscience, Centre of Psychiatry Research, Karolinska Institutet , Stockholm, Sweden
                [2] 2 Department for Forensic Psychiatry, National Board of Forensic Medicine , Stockholm, Sweden
                [3] 3 Department for Forensic Psychiatry, National Board of Forensic Medicine , Gothenburg, Sweden
                [4] 4 Centre for Ethics, Law and Mental Health, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg , Gothenburg, Sweden
                [5] 5 Forensic Psychiatric Clinic, Sahlgrenska University Hospital , Gothenburg, Sweden
                [6] 6 Department of Physiology and Pharmacology, Karolinska Institutet , Stockholm, Sweden
                [7] 7 Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) , Stockholm, Sweden
                [8] 8 Department of Neuroscience, Psychiatry, Uppsala University , Uppsala, Sweden
                [9] 9 Department of Philosophy, Linguistics, Theory of Science, University of Gothenburg , Gothenburg, Sweden
                Author notes

                Edited by: Harry G. Kennedy, Trinity College Dublin, Ireland

                Reviewed by: Birgit Angela Völlm, University of Rostock, Germany; Vivek Anthony Furtado, University of Warwick, United Kingdom

                *Correspondence: Katarina Howner, katarina.howner@ 123456ki.se

                This article was submitted to Forensic Psychiatry, a section of the journal Frontiers in Psychiatry

                Article
                10.3389/fpsyt.2019.00963
                6976536
                31164844
                f437fe68-59e0-4721-a6b0-7d9b17d4bab4
                Copyright © 2020 Howner, Andiné, Engberg, Ekström, Lindström, Nilsson, Radovic and Hultcrantz

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 17 December 2018
                : 05 December 2019
                Page count
                Figures: 1, Tables: 2, Equations: 0, References: 33, Pages: 12, Words: 6022
                Categories
                Psychiatry
                Systematic Review

                Clinical Psychology & Psychiatry
                forensic psychiatric care,mentally disordered offenders,pharmacological treatment,systematic review,antipsychotics

                Comments

                Comment on this article